Furneri, G. et al. 2016. [Cost-effectiveness analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy]. Farmeconomia. Health economics and therapeutic pathways. 17, 2 (Jun. 2016), 67–80. DOI:https://doi.org/10.7175/fe.v17i2.1251.